礼来公司宣布,其Achieve-3试验取得积极的顶线结果,该试验旨在评估奥福格列普隆与口服司美格鲁肽在安全性和有效性方面的表现对比。
礼来公司宣布,其Achieve-3试验取得积极的顶线结果,该试验旨在评估奥福格列普隆与口服司美格鲁肽在安全性和有效性方面的表现对比。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.